Friday, October 31, 2014 1:39:57 AM
RBSM helps public companies with financial statement audits, review of form 10k filings, mergers and acquisitions, amongst a suite of other services.
I'm not sure that an uplisting makes a lot of sense at this stage for a company like BION. My guess is, if there is not an uplist by the time ground breaks on the first plant in Taylor, then I suspect an uplist may happen near plant 1 completion. I believe what most investors want to see is: can not only BION succeed in getting it's inaugural plant to completion, but are it's products viable?
For most longs like myself, just wanting to see all 3 phases complete for EPC makes us happy because we feel we've been here from the beginning. We are the early adopters and we feel ownership of a new product and technology. I suspect though the broader market want's more substance and a reliable product before it decides to invest in this technology.
1. EPC completion = early adopters are happy / outside watchers still wonder what EPC is.
2. Plant 1 construction begins = early adopters ecstatic / outside watchers say: does company have the will to follow through completion given the human resource/legal/environmental landscape challenges?
3. Plant 1 construction complete = early adopters proud / outside watchers say: Well now that plant is complete, is technology proven? Will product meet standards set out at beginning of the venture? Can you deliver a profit? Is the company viable?
4. If landmarks are met I can see an uplist very quickly to OTC.QB or OTC.QX possibly even Nasdaq if things go according to plan.
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM